Simeng Wang
Shenyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Tumor immune microenvironment facilitates resistance to KRAS G12C inhibitor sotorasib by altered PD-L1 expression.
Journal: Journal for immunotherapy of cancer
Published: January 20, 2026
Activation of epigenetic reprogramming via crotonylation overcomes resistance to EGFR-TKI therapy in lung cancer.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 30, 2025
Revealing the impact of modified modules flexibility on gemcitabine prodrug nanoassemblies for effective cancer therapy.
Journal: Journal of colloid and interface science
Published: June 12, 2024
Loss of CDKN2A Enhances the Efficacy of Immunotherapy in EGFR-Mutant Non-Small Cell Lung Cancer.
Journal: Cancer research
Published: May 31, 2024
Loss of AXIN1 regulates response to lenvatinib through a WNT/KDM5B/p15 signalling axis in hepatocellular carcinoma.
Journal: British journal of pharmacology
Published: April 02, 2024
Precise engineering of disulfide bond-bridged prodrug nanoassemblies to balance antitumor efficacy and safety.
Journal: Acta biomaterialia
Published: September 16, 2022
Development of a UPLC-MS/MS method for the simultaneous determination of atorvastatin, 2-hydroxy atorvastatin, and naringenin in rat plasma and its application to pharmacokinetic interaction studies.
Journal: Biomedical chromatography : BMC
Published: April 25, 2022
Ultra-high performance supercritical fluid chromatography-tandem mass spectrometry method for simultaneous determination of atorvastatin, 2-hydroxy atorvastatin, and tangeretin in rat plasma and its application to the pharmacokinetic study.
Journal: Journal of separation science
Published: March 02, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026